SCHEMBL25697451

SCHEMBL25697451

Cc1cc(Cl)nn(COCC[Si](C)(C)C)c1=O

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.35
DGAT1 O75907 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160484 0.84 DGAT1 (0.36) NPC1DGAT1
SCHEMBL25219333 0.81 DGAT1 (0.39) NPC1DGAT1
SCHEMBL31381549 0.80 DGAT1 (0.33) NPC1DGAT1
SCHEMBL25408348 0.78 DGAT1 (0.34) NPC1DGAT1
SCHEMBL25697511 0.78 NPC1 (0.34) NPC1DGAT1
SCHEMBL29109010 0.77 KDM4E (0.34) NPC1DGAT1
SCHEMBL173652 0.76 ALDH1A1 (0.38) DGAT1
SCHEMBL25697513 0.76 NPC1 (0.33) NPC1DGAT1
SCHEMBL31022044 0.75 DGAT1 (0.33) NPC1DGAT1
SCHEMBL19981708 0.75 DGAT1 (0.30) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183216-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES GILEAD SCIENCES, INC. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183216-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES PIR, CYP3A43, CYP1A2 NPC1 1354/4885DGAT1 4685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.